That's empirically not true; the first such product approved for clinical use entered the market in the late 90s, and they've had small-to-medium success since. Definitely none of them changed things radically, but it's pretty common CAD functionality now and has both detractors and champions.
> Radiologists can fly through those exams with high quality,
This is also not entirely true, one of the biggest problems for screening (not diagnostic) programs is that the false negative rate for radiologists is high. They do fly through these scans, but that's to make it economically feasible. Also, the average radiologist performance on screening mammo is not very good - most have to do it regularly (probably 100s per month) to do it well.
You are right that augmentation is the more plausible path to clinical success, but that's been what most of the clinical systems aim to do anyways, provide a sanity check on the radiologist.